CENTER ON BEHAVIORAL MEDICINE

BODY-MIND CONNECTION

ENVIRONMENTAL INTOLERANCES and TOXINS

Environmental Intolerances and Toxins-Chemical:  Research Article
Environmental Intolerances Menu

Environmental Sensitivities

CITATION:  Joffres, MR, Williams, T, et al.  (2001).  Environmental Sensitivities: Prevalence of Major Symptoms in a Referral Center: The Nova Scotia Environmental Sensitivities Research Center Study,  Environmental Sensitivities: Prevalence of Major Symptoms in a Referral Center: The Nova Scotia Environmental Sensitivities Research Center Study.

ABSTRACT:
Environmental sensitivities (ES) are still considered by many to be an enigmatic health concern. Within the medical community, disparate views on the origins and pathophysiology abound (1–15). Nevertheless, individuals continue to experience symptoms that produce varying degrees of disability. The most frequently cited term to describe this clustering of medically unexplained symptoms has been multiple chemical sensitivities (MCS), originally coined by Cullen in his initial paper on workplace health risks (16). Several theories have been advanced to explain the diverse symptoms occurring after exposure to low-level irritants, foods, or electromagnetic radiation (1,3,4,5–15). In the 1995 Nova Scotia Health Survey, 3% of the population reported being environmentally sensitive (17). A more recent study conducted by Kreutzer et al. (18) stated that 16% of Californians reported being “allergic or unusually sensitive to everyday chemicals.” There were no specific questions on symptoms other than a list of products or situations “bothering” or making individuals “sick.” In a telephone survey conducted in North Carolina, Meggs et al. found that 33% of those surveyed reported sensitivity to chemicals (19), and 4% of the total population reported daily or almost daily frequency of their symptoms. The most common symptoms among individuals with chemical sensitivity were nausea (47%), headache (33%), and eye irritation (16%). There was no detailed evaluation of symptoms in this phone interview survey. Kipen et al. (20) found a prevalence of sensitivity to chemicals of 13% among Gulf Registry Veterans (20). Common within all these reports was the need to explore further and more accurately describe this phenomenon. To answer this need, we used a symptom-based questionnaire to explore the frequency, severity, and type of symptoms experienced by a Canadian patient population referred to a specialty center for environmental sensitivities.

References

1. Ashford NA, Miller CS. Chemical Exposures: Low Levels
and High Stakes. New York:Van Nostrand Reinhold, 1991.

2. Davidoff AL, Fogarty L. Psychogenic origins of multiple
chemical sensitivities syndrome: a critical review of the
research literature. Arch Environ Health 49:316–325 (1994).

3. Kipen HM, Fiedler N. Invited commentary: sensitivities to
chemicals—context and implications. Am J Epidemiol
150:13–16 (1999).

4. Neutra RR, Kreutzer R. Reply to “invited commentary:
sensitivities to chemicals—context and implications” by
Kipen and Fiedler. Am J Epidemiol 150:17 (1999).

5. Barrett S, Gots RE. Chemical Sensitivity: The Truth about
Environmental Illness. Amherst, NY:Prometheus Books,
1999.

6. Staudenmayer H. Multiple chemical sensitivities or idiopathic
environmental intolerances: psychophysiologic
foundation of knowledge for a psychogenic explanation.
J Allergy Clin Immunol 99:434–437 (1997).

7. Sparks PJ, Daniell W, Black DW, Kipen HM, Altman LC,
Simon GE, Terr AI. Multiple chemical sensitivity syndrome:
a clinical perspective. I. Case definition, theories
of pathogenesis, and research needs. Occup Med
36(7):718–730 (1994).

8. Meggs WJ. Neurogenic inflammation and sensitivity to
environmental chemicals. Environ Health Perspect
101:234–238 (1993).

9. Bascom R. Multiple chemical sensitivity: a respiratory
disorder? Toxicol Ind Health 8:221–228 (1992).

10. Antelman SM. Time-dependent sensitization in animals:
a possible model of multiple chemical sensitivity in
humans. Toxicol Ind Health 10:335–342 (1994).

11. Gilbert ME. The phenomenology of limbic kindling.
Toxicol Ind Health 10:343–358 (1994).

12. Miller CS. Possible models for multiple chemical sensitivity:
conceptual issues and role of the limbic system.
Toxicol Ind Health 8:181–202 (1992).

13. Bell IR. White paper: neuropsychiatric aspects of sensitivity
to low-level chemicals: a neural sensitization
model. Toxicol Ind Health 10:277–312 (1994).

14. Overstreet DH, Djuric V. Links between multiple chemical
sensitivity and asthma in a rat model of cholinergic hypersensitivity:
a brief review. Toxicol Ind Health 15:517–521
(1999).

15. Bell IR, Szarek MJ, Dicenso DR, Baldwin CM, Schwartz
GE, Bootzin RR. Patterns of waking EEG spectral power
in chemically intolerant individuals during repeated
chemical exposures. Int J Neurosci 97(1–2):41–59 (1999).

16. Cullen MR. The worker with multiple chemical sensitivities:
an overview. Occup Med 2:655–661 (1987).

17. Nova Scotia Department of Health. The Nova Scotia
Health Survey, 1995. Halifax (NS):Communications Nova
Scotia, 1996.

18. Kreutzer R, Neutra RR, Lashuay N. Prevalence of people
reporting sensitivities to chemicals in a populationbased
survey. Am J Epidemiol 150:1–12 (1999).

19. Meggs WJ, Dunn KA, Bloch RM, Goodman PE, Davidoff
AL. Prevalence and nature of allergy and chemical sensitivity
in a general population. Arch Environ Health
51:275–282 (1996).

20. Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH.
Prevalence of chronic fatigue and chemical sensitivities in
Gulf Registry Veterans. Arch Environ Health 54(5):313–318
(1999).

21. Multiple Chemical Sensitivity: A 1999 Consensus. Arch
Environ Health 54:147–149 (1999).

22. McKeown-Eyssen G, Marshall L, Ross G, Krondl M,
Sokoloff E. The University of Toronto Health Survey on
Environmental Hypersensitivity. A Report to the Ontario
Ministry of Health. Toronto, Canada:Ontario Ministry of
Public Health Publications, 1994.

23. McKeown-Eyssen GE, Sokoloff ER, Jazmaji V, Marshall
LM, Baines CJ. Reproducibility of the University of Toronto
self-administered questionnaire used to assess environmental
sensitivity. Am J Epidemiol 151(12):1216–1222
(2000).

24. MacLean DR, Petrasovits A, Nargundkar M, Connelly PW,
MacLeod E, Edwards A, Hessel P. Canadian heart health
surveys: a profile of cardiovascular risk. Survey methods
and data analysis. Canadian Heart Health Surveys
Research Group. Can Med Assoc J 146(11):1969–1674
(1992).

25. Sharabi Y, Danon YL, Berkenstadt H, Almog S, Mimouni-
Bloch A, Zisman A, Dani S, Atsmon J. Survey of symptoms
following intake of pyridostigmine during the
Persian Gulf war. Isr J Med Sci 27(11–12):656–658 (1991).

26. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-
Kaspa I. Pyridostigmine brain penetration under stress
enhances neuronal excitability and induces early immediate
transcriptional response. Nat Med 2(12):1382–1385
(1996).

27. Hu H, Stern A, Rotnitzky A, Schlesinger L, Proctor S,
Wolfe J. Development of a brief questionnaire for
screening for multiple chemical sensitivity syndrome.
Toxicol Ind Health 15(6):582–588 (1999).

28. Davidoff AL, Fogarty L, Keyl PM. Psychiatric inferences
from data on psychologic/psychiatric symptoms in multiple
chemical sensitivities syndrome. Arch Environ Health
55(3):165–175 (2000).

29. Doty RL. Olfaction and multiple chemical sensitivity.
Toxicol Ind Health 10:359–368 (1994).

30. Fox AR, Sabo BMT, Williams TPW, Joffres MR. Intradermal
Testing for Food and Chemical Sensitivity: A Double-Blind
Controlled Study. J Allergy Clin Immunol 103:907–911 (1999).

31. American College of Occupational and Environmental
Medicine. New Position Statement on MCS. Available:
http://www.acoem.org/paprguid/papers/mcs.htm [cited
15 December 2000].

32. Thompson GM, Day JH, Evers S, Gerrard JW, McCourtie
DR, Woodward WD. Report of the Ad Hoc Committee on
Environmental Hpersensitivity Disorders. Toronto,
Canada:Ontario Ministry of Health Publications (1985).

33. Randolph TG. Sensitivity to petroleum: including its derivatives
and antecedents. J Lab Clin Med 40:931–932 (1952).